Results 141 to 150 of about 11,628 (203)

AXL is a novel ERK5/KLF4 target in MEK inhibitor-treated melanoma. [PDF]

open access: yesNeoplasia
Paudel R   +5 more
europepmc   +1 more source

Dual regulation of CXCR6<sup>+</sup>CD8<sup>+</sup> T cells modulates cytotoxic and exhaustion-associated programs during prostate cancer progression. [PDF]

open access: yesJ Immunother Cancer
Xingming Z   +12 more
europepmc   +1 more source

Targeting lncRNA RP11-358L4.1 attenuates breast cancer cell proliferation and is associated with cell cycle and immune-related transcriptomic signatures. [PDF]

open access: yesWorld J Surg Oncol
Yangyang Z   +11 more
europepmc   +1 more source

Modulating <i>Bacteroides</i> to boost anti-PD-1 immunotherapy in HCC. [PDF]

open access: yesJ Immunother Cancer
Qi X   +8 more
europepmc   +1 more source

Targeting CDC42 Protects Mitochondrial Function through KLF2/HIF-1α/PINK1 Signaling in Acute Kidney Injury. [PDF]

open access: yesInt J Biol Sci
Zhou X   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy